← FDA Drug Approvals (Drugs@FDA)

MEPROSPAN

NDA · New Drug Application · Sponsor: MEDPOINTE PHARM HLC

Drug application

FDA Application #

NDA011284

Application type

New Drug Application

Brand name

MEPROSPAN

Generic name

Meprobamate

Active ingredients

MEPROBAMATE

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

MEDPOINTE PHARM HLC

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown